WHO《慢性丙型肝炎病毒感染者的筛查、护理和治疗指南》(2016年更新版)解读
Chinese Journal of Clinical Infectious Diseases(2016)
Abstract
2014年,世界卫生组织(WHO)颁布了首部Guidelines for the screening, care and treatment ofpersons with hepatitis C infection[1],该指南对慢性丙型肝炎(CHC)的治疗推荐以干扰素(IFN)为主;同时,HCV 治疗新药———直接抗病毒药物(Directacting antivirals,DAAs)的研发也进入快速发展阶段,结合DAAs 单药和联合治疗HCV 感染患者的循证医学证据,2016年WHO 对指南进行了更新,本文重点解读更新版指南中关于HCV 感染者治疗药物推荐和特殊人群感染者的处理意见。
MoreKey words
Hepatitis C,chronic,World health organization,Nursing care,Treatment outcome,Screening
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined